Ignite Creation Date:
2024-05-06 @ 12:34 AM
Last Modification Date:
2024-10-26 @ 10:51 AM
Study NCT ID:
NCT01600365
Status:
UNKNOWN
Last Update Posted:
2012-05-17
First Post:
2011-03-22
Brief Title:
Evaluate the Use of Ganciclovir Gel 03 for the Treatment of Conjunctivitis Caused by Adenovirus
Sponsor:
Adapt Produtos Oftalmológicos Ltda
Organization:
Adapt Produtos Oftalmológicos Ltda
Study Overview
Official Title:
Prospective Interventional Randomized Double-masked With the Use of Ganciclovir Gel 03 for Treatment of Conjunctivitis Caused by Adenovirus
Status:
UNKNOWN
Status Verified Date:
2012-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study the use of ganciclovir gel 03 for treatment of conjunctivitis caused by adenovirus
Detailed Description:
To evaluate the efficacy and tolerability of ganciclovir ophthalmic gel for the treatment of conjunctivitis comparing to placebo ophthalmic gel Visual acuity test and slit lamp examination biomicroscopy will be performed at each visit to assess the signssymptoms and the regression of the disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None